{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T21:48:45Z","timestamp":1762033725628,"version":"build-2065373602"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,1]]},"DOI":"10.7759\/cureus.95916","type":"journal-article","created":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T21:42:14Z","timestamp":1762033334000},"source":"Crossref","is-referenced-by-count":0,"title":["A Comparative Study on the Efficacy, Safety and Cost Effectiveness of Gabapentin and Pregabalin in the Treatment of Neuropathic Pain"],"prefix":"10.7759","author":[{"given":"Riya","family":"Kataria","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kranthi K","family":"Kadal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sundar","family":"Shanmugam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pallavi","family":"Setya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Classification of chronic pain. Descriptions of chronic pain syndromes and definitions of pain terms. Prepared by the International Association for the Study of Pain, Subcommittee on Taxonomy","volume":"3","year":"1986","unstructured":"Classification of chronic pain. Descriptions of chronic pain syndromes and definitions of pain terms. Prepared by the International Association for the Study of Pain, Subcommittee on Taxonomy. Pain Suppl. 1986, 3.S1-226.","journal-title":"Pain Suppl"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.sc.3101641","article-title":"Neuropathic pain after traumatic spinal cord injury - relations to gender, spinal level, completeness, and age at the time of injury","volume":"42","author":"Werhagen L","year":"2004","unstructured":"Werhagen L, Budh CN, Hultling C, Molander C. Neuropathic pain after traumatic spinal cord injury - relations to gender, spinal level, completeness, and age at the time of injury. Spinal Cord. 2004, 42:665-73. 10.1038\/sj.sc.3101641","journal-title":"Spinal Cord"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1590\/s0004-282x2009000100007","article-title":"Sleep patterns and symptoms of anxiety and depression in patients with chronic pain","volume":"67","author":"Castro MM","year":"2009","unstructured":"Castro MM, Daltro C. Sleep patterns and symptoms of anxiety and depression in patients with chronic pain. Arq Neuropsiquiatr. 2009, 67:25-8. 10.1590\/s0004-282x2009000100007","journal-title":"Arq Neuropsiquiatr"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2165\/11536200-000000000-00000","article-title":"A comparison of the pharmacokinetics and pharmacodynamics of pregabalin and gabapentin","volume":"49","author":"Bockbrader HN","year":"2010","unstructured":"Bockbrader HN, Wesche D, Miller R, Chapel S, Janiczek N, Burger P. A comparison of the pharmacokinetics and pharmacodynamics of pregabalin and gabapentin. Clin Pharmacokinet. 2010, 49:661-9. 10.2165\/11536200-000000000-00000","journal-title":"Clin Pharmacokinet"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2147\/ndt.s1715","article-title":"Clinical use of pregabalin in the management of central neuropathic pain","volume":"3","author":"Finnerup NB","year":"2007","unstructured":"Finnerup NB, Jensen TS. Clinical use of pregabalin in the management of central neuropathic pain. Neuropsychiatr Dis Treat. 2007, 3:885-91. 10.2147\/ndt.s1715","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref6","article-title":"Comparative study of efficacy and safety of pregabalin and gabapentin in neuropathic pain","volume":"2","author":"Ghosh AK","year":"2012","unstructured":"Ghosh AK, Ghosh A, Kundu A, Das AK, Bhattacharya KB. Comparative study of efficacy and safety of pregabalin and gabapentin in neuropathic pain. Asian Journal of Pharmacy and Life Science. 2012, 2:64-71.","journal-title":"Asian Journal of Pharmacy and Life Science"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.2","article-title":"Neuropathic pain","volume":"3","author":"Colloca L","year":"2017","unstructured":"Colloca L, Ludman T, Bouhassira D, et al.. Neuropathic pain. Nat Rev Dis Primers. 2017, 3:17002. 10.1038\/nrdp.2017.2","journal-title":"Nat Rev Dis Primers"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2008.04.023","article-title":"A prospective identification of neuropathic pain in specific chronic polyneuropathy syndromes and response to pharmacological therapy","volume":"138","author":"Toth C","year":"2008","unstructured":"Toth C, Au S. A prospective identification of neuropathic pain in specific chronic polyneuropathy syndromes and response to pharmacological therapy. Pain. 2008, 138:657-66. 10.1016\/j.pain.2008.04.023","journal-title":"Pain"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2005.08.013","article-title":"Algorithm for neuropathic pain treatment: an evidence based proposal","volume":"118","author":"Finnerup NB","year":"2005","unstructured":"Finnerup NB, Otto M, McQuay HJ, Jensen TS, Sindrup SH. Algorithm for neuropathic pain treatment: an evidence based proposal. Pain. 2005, 118:289-305. 10.1016\/j.pain.2005.08.013","journal-title":"Pain"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.12968\/ijpn.2008.14.1.28149","article-title":"Diagnosis and management of neuropathic pain in palliative care","volume":"14","author":"Callin S","year":"2008","unstructured":"Callin S, Bennett MI. Diagnosis and management of neuropathic pain in palliative care. Int J Palliat Nurs. 2008, 14:16-21. 10.12968\/ijpn.2008.14.1.28149","journal-title":"Int J Palliat Nurs"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2004.11.007","article-title":"The S-LANSS score for identifying pain of predominantly neuropathic origin: validation for use in clinical and postal research","volume":"6","author":"Bennett MI","year":"2005","unstructured":"Bennett MI, Smith BH, Torrance N, Potter J. The S-LANSS score for identifying pain of predominantly neuropathic origin: validation for use in clinical and postal research. J Pain. 2005, 6:149-58. 10.1016\/j.jpain.2004.11.007","journal-title":"J Pain"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2004.12.010","article-title":"Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4)","volume":"114","author":"Bouhassira D","year":"2005","unstructured":"Bouhassira D, Attal N, Alchaar H, et al.. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain. 2005, 114:29-36. 10.1016\/j.pain.2004.12.010","journal-title":"Pain"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/s1526-5900(03)00716-8","article-title":"Interpretation of visual analog scale ratings and change scores: a reanalysis of two clinical trials of postoperative pain","volume":"1","author":"Jensen MP","year":"2003","unstructured":"Jensen MP, Chen C, Brugger AM. Interpretation of visual analog scale ratings and change scores: a reanalysis of two clinical trials of postoperative pain. J Pain. 2003, 1:407-14. 10.1016\/s1526-5900(03)00716-8","journal-title":"J Pain"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/ACO.0b013e32830c900c","article-title":"Acute neuropathic pain: diagnosis and treatment","volume":"21","author":"Gray P","year":"2008","unstructured":"Gray P. Acute neuropathic pain: diagnosis and treatment. Curr Opin Anaesthesiol. 2008, 21:590-5. 10.1097\/ACO.0b013e32830c900c","journal-title":"Curr Opin Anaesthesiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurol.2018.08.005","article-title":"Pharmacological treatments of neuropathic pain: the latest recommendations","volume":"175","author":"Attal N","year":"2019","unstructured":"Attal N. Pharmacological treatments of neuropathic pain: the latest recommendations. Rev Neurol (Paris). 2019, 175:46-50. 10.1016\/j.neurol.2018.08.005","journal-title":"Rev Neurol (Paris)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/PR9.0000000000001138","article-title":"A systematic review and meta-analysis of randomized controlled head-to-head trials of recommended drugs for neuropathic pain","volume":"9","author":"Sadegh AA","year":"2024","unstructured":"Sadegh AA, Gehr NL, Finnerup NB. A systematic review and meta-analysis of randomized controlled head-to-head trials of recommended drugs for neuropathic pain. Pain Rep. 2024, 9:e1138. 10.1097\/PR9.0000000000001138","journal-title":"Pain Rep"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.6026\/973206300200386","article-title":"Efficacy of pregabalin, amitriptyline, and gabapentin for neuropathic pain","volume":"20","author":"Trivedi PD","year":"2024","unstructured":"Trivedi PD, Posani S, Balla N, et al.. Efficacy of pregabalin, amitriptyline, and gabapentin for neuropathic pain. Bioinformation. 2024, 20:386-90. 10.6026\/973206300200386","journal-title":"Bioinformation"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1177\/1049909111412539","article-title":"A comparative efficacy of amitriptyline, gabapentin, and pregabalin in neuropathic cancer pain: a prospective randomized double-blind placebo-controlled study","volume":"29","author":"Mishra S","year":"2012","unstructured":"Mishra S, Bhatnagar S, Goyal GN, Rana SP, Upadhya SP. A comparative efficacy of amitriptyline, gabapentin, and pregabalin in neuropathic cancer pain: a prospective randomized double-blind placebo-controlled study. Am J Hosp Palliat Care. 2012, 29:177-82. 10.1177\/1049909111412539","journal-title":"Am J Hosp Palliat Care"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2018.3077","article-title":"Effect of gabapentin vs pregabalin on pain intensity in adults with chronic sciatica: a randomized clinical trial","volume":"76","author":"Robertson K","year":"2019","unstructured":"Robertson K, Marshman LA, Plummer D, Downs E. Effect of gabapentin vs pregabalin on pain intensity in adults with chronic sciatica: a randomized clinical trial. JAMA Neurol. 2019, 76:28-34. 10.1001\/jamaneurol.2018.3077","journal-title":"JAMA Neurol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/papr.12014","article-title":"A randomized, controlled trial of gabapentin enacarbil in subjects with neuropathic pain associated with diabetic peripheral neuropathy","volume":"13","author":"Rauck R","year":"2013","unstructured":"Rauck R, Makumi CW, Schwartz S, et al.. A randomized, controlled trial of gabapentin enacarbil in subjects with neuropathic pain associated with diabetic peripheral neuropathy. Pain Pract. 2013, 13:485-96. 10.1111\/papr.12014","journal-title":"Pain Pract"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1001\/jama.280.21.1837","article-title":"Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial","volume":"280","author":"Rowbotham M","year":"1998","unstructured":"Rowbotham M, Harden N, Stacey B, Bernstein P, Magnus-Miller L. Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. JAMA. 1998, 280:1837-42. 10.1001\/jama.280.21.1837","journal-title":"JAMA"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.60.11.1524","article-title":"Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations","volume":"60","author":"Dworkin RH","year":"2003","unstructured":"Dworkin RH, Backonja M, Rowbotham MC, et al.. Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch Neurol. 2003, 60:1524-34. 10.1001\/archneur.60.11.1524","journal-title":"Arch Neurol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(02)00255-5","article-title":"Gabapentin in neuropathic pain syndromes: a randomised, double-blind, placebo-controlled trial","volume":"99","author":"Serpell MG","year":"2002","unstructured":"Serpell MG, Neuropathic Pain Study Group. Gabapentin in neuropathic pain syndromes: a randomised, double-blind, placebo-controlled trial. Pain. 2002, 99:557-66. 10.1016\/S0304-3959(02)00255-5","journal-title":"Pain"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1111\/papr.13424","article-title":"Comparing the effectiveness of pregabalin and gabapentin in patients with lumbar radiculopathy: a systematic review and meta-analysis","volume":"25","author":"Kwon DY","year":"2024","unstructured":"Kwon DY, Kim KR, Kim DH, Kwak SG. Comparing the effectiveness of pregabalin and gabapentin in patients with lumbar radiculopathy: a systematic review and meta-analysis. Pain Pract. 2024, 25:10.1111\/papr.13424","journal-title":"Pain Pract"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1001\/jama.280.21.1831","article-title":"Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial","volume":"280","author":"Backonja M","year":"1998","unstructured":"Backonja M, Beydoun A, Edwards KR, et al.. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA. 1998, 280:1831-6. 10.1001\/jama.280.21.1831","journal-title":"JAMA"},{"key":"ref26","article-title":"A2delta ligands gabapentin and pregabalin: future implications in daily clinical practice","volume":"14","author":"Tzellos TG","year":"2010","unstructured":"Tzellos TG, Papazisis G, Toulis KA, Sardeli Ch, Kouvelas D. A2delta ligands gabapentin and pregabalin: future implications in daily clinical practice. Hippokratia. 2010, 14:71-5.","journal-title":"Hippokratia"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2007.06.033","article-title":"Pregabalin in patients with central neuropathic pain: a randomized, double-blind, placebo-controlled trial of a flexible-dose regimen","volume":"136","author":"Vranken JH","year":"2008","unstructured":"Vranken JH, Dijkgraaf MG, Kruis MR, van der Vegt MH, Hollmann MW, Heesen M. Pregabalin in patients with central neuropathic pain: a randomized, double-blind, placebo-controlled trial of a flexible-dose regimen. Pain. 2008, 136:150-7. 10.1016\/j.pain.2007.06.033","journal-title":"Pain"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.apmr.2007.07.038","article-title":"Comparison of the effectiveness of amitriptyline and gabapentin on chronic neuropathic pain in persons with spinal cord injury","volume":"88","author":"Rintala DH","year":"2007","unstructured":"Rintala DH, Holmes SA, Courtade D, Fiess RN, Tastard LV, Loubser PG. Comparison of the effectiveness of amitriptyline and gabapentin on chronic neuropathic pain in persons with spinal cord injury. Arch Phys Med Rehabil. 2007, 88:1547-60. 10.1016\/j.apmr.2007.07.038","journal-title":"Arch Phys Med Rehabil"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2006.11.017","article-title":"Cost-effectiveness of pregabalin for the management of neuropathic pain associated with diabetic peripheral neuropathy and postherpetic neuralgia: a Canadian perspective","volume":"28","author":"Tarride JE","year":"2006","unstructured":"Tarride JE, Gordon A, Vera-Llonch M, Dukes E, Rousseau C. Cost-effectiveness of pregabalin for the management of neuropathic pain associated with diabetic peripheral neuropathy and postherpetic neuralgia: a Canadian perspective. Clin Ther. 2006, 28:1922-34. 10.1016\/j.clinthera.2006.11.017","journal-title":"Clin Ther"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-13-56","article-title":"Pregabalin versus gabapentin in the management of peripheral neuropathic pain associated with post-herpetic neuralgia and diabetic neuropathy: a cost effectiveness analysis for the Greek healthcare setting","volume":"13","author":"Athanasakis K","year":"2013","unstructured":"Athanasakis K, Petrakis I, Karampli E, Vitsou E, Lyras L, Kyriopoulos J. Pregabalin versus gabapentin in the management of peripheral neuropathic pain associated with post-herpetic neuralgia and diabetic neuropathy: a cost effectiveness analysis for the Greek healthcare setting. BMC Neurol. 2013, 13:56. 10.1186\/1471-2377-13-56","journal-title":"BMC Neurol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/417737-a-comparative-study-on-the-efficacy-safety-and-cost-effectiveness-of-gabapentin-and-pregabalin-in-the-treatment-of-neuropathic-pain","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T21:42:15Z","timestamp":1762033335000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/417737-a-comparative-study-on-the-efficacy-safety-and-cost-effectiveness-of-gabapentin-and-pregabalin-in-the-treatment-of-neuropathic-pain"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,1]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.95916","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,1]]}}}